『Sheppard Mullin's Health-e Law』のカバーアート

Sheppard Mullin's Health-e Law

Sheppard Mullin's Health-e Law

著者: Sheppard Mullin with Phil Kim and Sara Shanti
無料で聴く

このコンテンツについて

A podcast dedicated to the exciting, and sometimes explosive, interaction between technology and law in the health space, covering innovations that impact healthcare, like artificial intelligence, virtual reality, and wearables. Hosted by Sheppard Mullin’s Digital Health Team, the Health-e Law podcast will dive into the legal implications of health-tech you should know about and visit with trailblazing players in the industry.Copyright © 2025 Sheppard Mullin. All Rights Reserved. 政治・政府
エピソード
  • AI in Clinical Research: Opportunities, Risks, and the Road Ahead with Bill Kish and Dr. Brad Pruitt of Kenosha AI
    2025/07/24
    Welcome to Health-e Law, Sheppard Mullin's podcast exploring the fascinating health tech topics and trends of the day. In this episode, Sara Shanti welcomes Bill Kish and Dr. Brad Pruitt of Kenosha AI to explore how artificial intelligence can enhance efficiency and compliance in healthcare research. What is Kenosha AI, and what is its potential role in transforming healthcare and research operations? Who are the end users of Kenosha AI’s products, and how are these products positioned to deliver immediate, tangible impacts for their missions? Looking ahead, how might this momentum build, and what direction could clinical research take with the advancements enabled by AI? What are the risks and concerns associated with hallucinations, synthetic data, and the trustworthiness of AI deliverables? Where can healthcare stakeholders feel comfortable jumping in on AI, and where does it make sense to wait for further development? What tasks should clinicians and researchers prioritize when exploring the potential applications of AI? About Bill Kish Bill Kish is the CEO and Co-Founder of Kenosha AI, bringing over 30 years of dynamic experience as a technologist, entrepreneur, and leader across five successful startups. His expertise has led burgeoning companies to flourish into multi-billion-dollar enterprises, solidifying his position as an industry innovator. A graduate with honors in Computer Engineering from Carnegie Mellon University, Bill’s career has been defined by groundbreaking advancements in AI and machine learning applications. He co-founded Ruckus Wireless, serving as CTO and Board Director, where his contributions shaped the company into a $400M/year business and a leader in the wireless technology industry, culminating in a $1.5 billion acquisition by Brocade. At Cogniac Corporation, Bill enabled industries to leverage AI-powered visual inspection, serving as the CEO and CTO to drive operational innovation. He also founded Jiggy AI, a boutique AI consulting firm specializing in large language model applications. Additionally, as the organizer of the Silicon Valley Machine Learning Meetup, Bill has fostered a thriving global community of over 10,000 members passionate about machine learning. About Dr. Brad Pruitt Dr. Brad Pruitt is the President and Co-Founder of Kenosha AI. With over 25 years of experience in clinical research and healthcare, including 13 years in the Contract Research Organization (CRO) industry, he specializes in revolutionizing clinical trials through advanced AI-powered tools like copilots and GPTs. Dr. Pruitt is a seasoned executive and entrepreneur with a proven track record of leading ventures to success. He has held executive roles at top-tier CROs, served as the Founding CEO of an acquired startup, and contributed to three successful acquisitions in the past eight years. His prior leadership roles include Chief Medical Officer at Alethium Health Systems, where he developed go-to-market strategies for clinical trial innovation, and Senior Vice President of Medical Affairs at Safe Health, where he drove business expansion into connected diagnostics. In addition to his role with Kenosha AI, Dr. Pruitt is a Principal at Prucor and serves as a mentor and advisor for healthcare and clinical trial technology companies participating in the EvoNexus incubator program. Dr. Pruitt earned his MD from Michigan State University College of Human Medicine and his MBA from UC San Diego’s Rady School of Management. His academic foundation, combined with his professional achievements, positions him as a visionary leader at the intersection of technology, healthcare, and clinical research. About Sara Shanti A partner in the Corporate Practice Group in Sheppard Mullin's Chicago office and co-lead of its Digital Health Team, Sara Shanti’s practice sits at the forefront of healthcare technology by providing practical counsel on novel innovation and complex data privacy matters. Using her medical research background and HHS experience, Sara advises providers, payors, start-ups, technology companies, and their investors and stakeholders on digital healthcare and regulatory compliance matters, including artificial intelligence (AI), augmented and virtual reality (AR/VR), gamification, implantable and wearable devices, and telehealth. At the cutting edge of advising on "data as an asset" programming, Sara's practice supports investment in innovation and access to care initiatives, including mergers and acquisitions involving crucial, high-stakes and sensitive data, medical and wellness devices, and web-based applications and care. Contact Information Bill Kish Dr. Brad Pruitt Sara Shanti Additional Resources Kenosha AI - Kenosha AI is currently offering a free trial of its RegChatTM, which is an AI-powered Clinical Regulatory Guidance Assistant that provides a simple chat interface for answering questions about global regulatory guidance using AI and official ...
    続きを読む 一部表示
    14 分
  • Navigating AI: Governance and Innovation at UCSD Health with Ron Skillens of UCSD Health
    2025/04/21

    Welcome to Health-e Law, Sheppard Mullin's podcast exploring the fascinating health tech topics and trends of the day. In this episode, Ron Skillens, Chief Compliance and Privacy Officer at UC San Diego Health, joins host and Sheppard Mullin partner Michael Orlando to discuss the transformative potential of AI in healthcare and the importance of balancing innovation with compliance.

    What We Discussed in This Episode:

    • How could AI transform patient care and hospital operations in the next five years?

    • With health data being as sensitive and valuable as it is, why is an AI governance structure crucial for the creative and compliant use of AI?

    • How can AI usage be effectively managed and coordinated between stakeholders to strike the right balance of innovation and risk?

    • What have been some of the biggest challenges and lessons learned when establishing an AI governance structure?

    • In what ways does patient interest shape the evaluation of AI applications in healthcare?

    • What is the best way to keep staff and stakeholders updated on the latest AI advancements, emerging trends and best practices?

    About Ron Skillens

    Ron Skillens is the chief compliance and privacy officer for UC San Diego Health. He is responsible for the mitigation of compliance and regulatory risks, pursuing leading practices and ensuring that all Health compliance and privacy activities are coordinated with the appropriate leaders.

    In addition, Mr. Skillens provides health care research compliance support for UC San Diego Health Sciences and is responsible for administering the health system’s policy and procedure process. He has more than 30 years of compliance, audit and risk management experience working with diverse senior leadership, physicians and boards, bringing to this position a demonstrated commitment to compliance and collaboration.

    About Michael Orlando

    Michael Orlando is a corporate and intellectual property transactions partner in Sheppard Mullin’s San Diego (Del Mar) office. He is Co-Team Leader of the firm's Technology Transactions Team, and a member of the Life Sciences and Digital Health teams. He founded a software-as-a-service (SaaS) business prior to attending law school, and worked at a publicly-traded biotechnology company on an in-house secondment, and uses that experience in bringing a practical, business-oriented approach to his engagements.

    For over 20 years, Michael has been assisting innovators, cutting-edge technology companies and other organizations develop, acquire, sell, and commercialize intellectual property assets, including technology licensing, commercial agreements, strategic partnerships, research, development and collaboration contracts, manufacturing and supply arrangements, outsourcing, and corporate transactions.

    Contact Information

    Ron Skillens

    Michael Orlando

    Additional Resources

    AI Governance Checklist

    Thank you for listening! Don't forget to SUBSCRIBE to the show to receive new episodes delivered straight to your podcast player every month.

    If you enjoyed this episode, please help us get the word out about this podcast. Rate and

    Review this show on Apple Podcasts, Amazon Music, or Spotify. It helps other listeners find this show.

    This podcast is for informational and educational purposes only. It is not to be construed as legal advice specific to your circumstances. If you need help with any legal matter, be sure to consult with an attorney regarding your specific needs.

    続きを読む 一部表示
    17 分
  • Crossroads of Care: Navigating Executive Orders with Jonathan Meyer, former DHS GC and Partner at Sheppard Mullin
    2025/02/25
    Welcome to Health-e Law, Sheppard Mullin's podcast exploring the fascinating health tech topics and trends of the day. In this episode, Jonathan Meyer, a partner at Sheppard Mullin and Leader of the firm’s National Security Team, joins us again to discuss the early days of the new Trump administration and what might be on the horizon in terms of cybersecurity and data privacy. What We Discussed in This Episode: What can we expect from the new administration in relation to cybersecurity and data protection? How do these concerns translate to healthcare, both in terms of managing our care and protecting our data? What is Sheppard Mullin’s executive actions tracker, why it matters, and how can listeners use it? How is healthcare struggling with privacy and immigration, and how does this impact national security? About Jonathan Meyer As a partner in Sheppard Mullin’s Governmental Practice Group and leader of the firm’s National Security team, Jonathan E. Meyer counsels clients on their interactions with federal and state government, as well as national and homeland security, Congressional oversight, cybersecurity, AI, high tech, and transportation security, among other issues. Prior to returning to Sheppard Mullin, Jon was nominated by President Biden and confirmed by the Senate as the Sixth General Counsel of the U.S. Department of Homeland Security, serving from 2021 to 2024. His decades of experience in Congress, the Justice Department and DHS position him to bring an insider’s perspective to interactions between private companies and the government. He has defended scores of Congressional investigations and has prepared witnesses for over 100 hearings, including Supreme Court nomination hearings, impeachment hearings, oversight hearings, high tech and antitrust investigations, and civil rights investigations, among others. He has also represented defendants and witnesses in high-stakes Justice Department criminal investigations. The media – including CBS News, NPR, The Wall Street Journal, The New York Times, The Washington Post and Politico – regularly turn to Jon for insight into issues regarding national security, homeland security, government investigations, cybersecurity, immigration, politics and Congress. He has twice been honored with the Secretary of Homeland Security’s Outstanding Service Medal, the highest civilian award bestowed by DHS. He has also received the U.S. Secret Service Director’s Honor Award, the Customs and Border Protection Commissioner’s Ensign Award, and the U.S. Coast Guard Commandant’s Distinguished Service Medal, among numerous other prestigious accolades recognizing his exceptional service. About Sara Shanti A partner in the Corporate Practice Group in the Sheppard Mullin's Chicago office and co-lead of its Digital Health Team, Sara Shanti’s practice sits at the forefront of healthcare technology by providing practical counsel on novel innovation and complex data privacy matters. Using her medical research background and HHS experience, Sara advises providers, payors, start-ups, technology companies, and their investors and stakeholders on digital healthcare and regulatory compliance matters, including artificial intelligence (AI), augmented and virtual reality (AR/VR), gamification, implantable and wearable devices, and telehealth. At the cutting edge of advising on "data as an asset" programming, Sara's practice supports investment in innovation and access to care initiatives, including mergers and acquisitions involving crucial, high-stakes and sensitive data, medical and wellness devices, and web-based applications and care. Contact Information Jonathan E. Meyer Sara Shanti Additional Resources Trump Executives Action Tracker Thank you for listening! Don't forget to SUBSCRIBE to the show to receive new episodes delivered straight to your podcast player every month. If you enjoyed this episode, please help us get the word out about this podcast. Rate and Review this show on Apple Podcasts, Amazon Music, or Spotify. It helps other listeners find this show. This podcast is for informational and educational purposes only. It is not to be construed as legal advice specific to your circumstances. If you need help with any legal matter, be sure to consult with an attorney regarding your specific needs.
    続きを読む 一部表示
    9 分
まだレビューはありません